Sponsor pipeline

Forma Therapeutics, Inc. clinical trial pipeline

Get alerts when Forma Therapeutics, Inc.'s trials change

3 active trials 2 recruiting 1 Phase 3 1 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

Active trials by phase

Phase 2
2
Phase 3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT04624659 A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS) Sickle Cell Disease Active, Not Recruiting 2026-04-06
Phase 2
NCT06198712 A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients… Sickle Cell Disease Recruiting 2026-09-18
NCT05953584 A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler… Sickle Cell Disease Recruiting 2026-09-10

Disease areas by active trials

Sickle Cell Disease (3)

Get alerts when Forma Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free